1301189-92-3

Basic information

• Product Name: 2-(4-biphenylyl)-N-methyl-1-[(3RS)-3-pyrrolidinylmethyl]-1H-benzimidazole-6-carboxamide
• Synonyms: 2-(4-biphenylyl)-N-methyl-1-[(3RS)-3-pyrrolidinylmethyl]-1H-benzimidazole-6-carboxamide
• CAS NO: 1301189-92-3
• Molecular Weight: 410.519
• Mol File: 1301189-92-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-(4-biphenylyl)-N-methyl-1-[(3RS)-3-pyrrolidinylmethyl]-1H-benzimidazole-6-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-biphenylyl)-N-methyl-1-[(3RS)-3-pyrrolidinylmethyl]-1H-benzimidazole-6-carboxamide(1301189-92-3)
• EPA Substance Registry System: 2-(4-biphenylyl)-N-methyl-1-[(3RS)-3-pyrrolidinylmethyl]-1H-benzimidazole-6-carboxamide(1301189-92-3)

Safety Data

• Hazardous Substances Data: 1301189-92-3(Hazardous Substances Data)

Upstream product

• 93138-61-5 C-(1-benzyl-pyrrolidin-3-yl)-methylamine 
• 270912-72-6 tert-butyl 3-(aminomethyl)pyrrolidine-1-carboxylate 
• 849632-74-2 2,2,2-trifluoro-N-{[(3RS)-1-(phenylmethyl)-3-pyrrolidinyl]methyl}acetamide 
• 1301189-91-2 1,1-dimethylethyl (3RS)-3-({2-(4-biphenylyl)-6-[(methylamino)carbonyl]-1H-benzimidazol-1-yl}methyl)-1-pyrrolidinecarboxylate 
• 1301189-89-8 2-(4-biphenylyl)-1-[((3R₅)-1-{[(1,1-dimethylethyl)oxy]carbonyl}-3-pyrrolidinyl)methyl]-1H-benzimidazole-6-carboxylic acid 
• 1301189-87-6 3-{[((3RS)-1-{[(1,1-dimethylethyl)oxy]carbonyl}-3-pyrrolidinyl)methyl]amino}-4-nitrobenzoic acid 
• 1301188-94-2 1,1-dimethylethyl (3RS)-3-{[(trifluoroacetyl)amino]methyl}-1-pyrrolidinecarboxylate 

Downstream Products

• 1301188-36-2 2-(4-biphenylyl)-1-({(3RS)-1-[(dimethylamino)carbonyl]-3-pyrrolidinyl}methyl)-N-methyl-1H-benzimidazole-6-carboxamide 
• 1301188-37-3 2-(4-biphenylyl)-N-methyl-1-({(3RS)-1-[(3-methyl-5-isoxazolyl)carbonyl]-3-pyrrolidinyl}methyl)-1H-benzimidazole-6-carboxamide 

Relevant articles and documents

BENZIMIDAZOLES AS FATTY ACID SYNTHASE INHIBITORS

This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of benzimidazoles in the treatment of cancer.